Learn more about the risks and benefits of LORBRENA® (lorlatinib), an Rx treatment option.

LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has …

How LORBRENA Works in the Brain The brain is a common site where ALK+ NSCLC spreads (metastasizes). One reason treating brain metastases can be challenging is that the medicine …

See risks and benefits. Learn more about how to help identify and manage potential side effects when taking LORBRENA® (lorlatinib).

See risks and benefits. Learn more about anaplastic lymphoma kinase positive non-small cell lung cancer that has spread to other parts of the body.

This brochure explains some of the side effects you may experience while taking LORBRENA and offers strategies that you can discuss with your healthcare provider to help manage some of …

LORBRENA® (lorlatinib) LORBRENA® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic …

Learn how Pfizer Oncology Together can help identify what financial support options may be available for patients taking Lorbrena®.

Newly diagnosed patients LORBRENA was evaluated in a clinical trial known as the CROWN trial. The trial studied 296 patients with ALK+ NSCLC whose cancer had spread to other parts of …

One subtype of lung cancer is ALK+ NSCLC. Living with ALK+ NSCLC can be challenging and sometimes discouraging, especially if it continues to grow or spread (known as “progression”). …